VIM and breast carcinoma: Regarding its metastatic potential, MTHFD2 appears to promote the epithelial-mesenchymal transition by upregulating vimentin and N-cadherin, where MTHFD2 depletion has been shown to impair the organization of the vimentin network required for cell motility and migration in breast cancer cells15 and in renal cancer32.